Skip to main content
. 2021 Feb 10;2021:4131420. doi: 10.1155/2021/4131420

Figure 4.

Figure 4

MaR1 treatment reduced OVA-induced Th2 cytokine levels in BALF. (a) IL-4 level in BALF. (b) IL-13 level in BALF. (c) IL-5 level in BALF. Data expressed as mean ± SEM (n = 6/group). #P < 0.05, ##P < 0.01 vs. the control group; ∗P < 0.05, ∗∗P < 0.01 vs. OVA.